In one paragraphArticle in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors at 4 institutions in 2 countries.
Alejandro Montoya-GómezGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.ORCID 0000-0002-0494-4207 Barbara SpolaoreDipartimento di Scienze del Farmaco, Università di Padova, Via F. Marzolo 5, 35131 Padova, Italy.ORCID 0000-0002-8284-8560 Maria Lina MassiminoIstituto di Neuroscienze, CNR, Via Ugo Bassi 58/B, 35131 Padova, Italy.
Leonel Montealegre-SánchezGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.ORCID 0000-0001-7057-717X Andrés CastilloTAO-Lab, Centre for Bioinformatics and Photonics-CIBioFi, Department of Biology, Universidad del Valle, Cali 760032, Colombia.ORCID 0000-0001-9006-6721 Nelson Rivera FrancoTAO-Lab, Centre for Bioinformatics and Photonics-CIBioFi, Department of Biology, Universidad del Valle, Cali 760032, Colombia.ORCID 0000-0002-4733-5452 María José Sevilla-SánchezGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.ORCID 0000-0003-4117-3736 Luis Manuel Solano-RedondoGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.
Mildrey Mosquera-EscuderoGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.ORCID 0000-0003-0783-5839 Eliécer Jiménez-CharrisGrupo de Nutrición, Facultad de Salud, Universidad del Valle, Cali 760043, Colombia.ORCID 0000-0001-6043-1521 Universidad del Valle · CONeuroscience Institute · ITUniversidad Autónoma de Occidente · COUniversity of Padua · IT
Funding
Colombian General Royalties System BPIN 2020000100053
6 · The paper itselfAbstract
Despite advances in chemotherapeutic drugs used against cervical cancer, available chemotherapy treatments adversely affect the patient's quality of life. For this reason, new molecules from natural sources with antitumor potential and few side effects are required. In previous research,
Indexed as
Antineoplastic AgentsUterine Cervical NeoplasmsCell AdhesionFemaleHeLa CellsHumansIntegrin alpha5beta1Quality of LifeAntineoplastic AgentsIntegrin alpha5beta1antitumor potentialbioprospectingmembrane receptor targetphospholipase A2snake venomtranscriptomic analysis
Identifiers
PMID38067143
PMCPMC10705806
OpenAlexW4389035956
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390